Grupo Biotoscana (GBT) is an advanced biopharmaceutical company in Latin America. With operations in 10 countries throughout the region, GBT maintains pan-regional presence with a focus on specialty pharmaceuticals, world-class licensed products and proprietary branded generics. GBT markets leading brands in the fields of high-complexity genetic disorders, rare disease, oncology, hematology, infectious disease, HIV and specialty treatments. Backed by Advent International and Essex Woodlands, GBT was later acquired by Knight Therapeutics Inc. (TSX: GUD)

ForeSee Medical is the healthcare industry’s leading software platform designed to increase the profitability of Medicare Advantage risk contracts. Using proprietary clinical algorithms, including natural language processing (NLP) and machine learning, ForeSee Medical perfects HCC risk adjustment scores, empowering providers to maximize health outcomes.

CPG Diagnostics is the developer of OvaPrint, a demonstrated liquid biopsy for early-stage epithelial ovarian cancer. Using Next Generation Sequencing, OvaPrint serves as a pre-operative diagnostic measuring cell-free DNA methylation. OvaPrint distinguishes between benign and malignant lesions with near perfect sensitivity and specificity, avoiding false positive or negatives and providing true confidence in early stage ovarian cancer diagnostics. OvaPrint is now under evaluation as an early detection screening test.

Ubiety is a next-generation security solution designed to increase community safety by identifying perpetrators in the process of committing a crime. Using a combined evolutionary sensor array and data analytics platform, Ubiety enables the last mile of identification by capturing data signals from a wide range of electronic devices . Ubiety users include individual home owners as well as municipal police departments in major cities throughout the country.

Stationhead is a fast-growing mobile social media network that allows everyone – music artists and fans alike - to become the DJ of their own global radio station, all from a smart phone. Stationhead is post-market, post-revenue and is partnered with the major streaming services including Apple and Spotify. Stationhead’s IP revolutionizes the calculation of music licensing fees through its proprietary de-coupling technology.

Oncology Ventures is a VC focused on Investing in healthcare data startups that enhance cancer care and research. Oncology Ventures invests in cancer-focused data, infrastructure, IT and services start-ups that look to fundamentally change the way cancer care is designed and delivered at scale.

Rhino is a comprehensive financial app that allows users to manage Bitcoin transactions, pay bills, borrow money, and invest in retirement accounts, all in one seamless and secure platform.

ZenCredit is a venture lending and syndication platform specializing in high-yield alternative finance. ZenCredit Ventures invests in post-market small business funding companies with a proven track record of success using scale, diversification and operational controls to mitigate risk. ZenCredit Systems is the first accelerator index of small business funding in the United States.

PeriShip provides high-touch, end-to-end logistics management from a sophisticated IT platform with proprietary databases, package and flight-tracking software, weather, and flight status monitoring systems, as well as dynamic dashboards with real-time visibility into shipment transit and last-mile events. In April 2022, Periship was acquired by VerifyMe Inc. (NASDAQ: VRME).

MPL Comex is a leading global trade facilitator specializing in multi-directional systems for both the import and export of consumer goods. With turn-key operations established worldwide, MPL ensures safe, efficient, and customizable programs for both exporting suppliers and importing customers.

Aqua Medical is an early stage medical device company that specializes in vapor ablation technology to treat a variety of gastrointestinal diseases including esophageal and pancreatic cancers. Aqua Medical’s disruptive pipeline endoscopic therapies serve as a platform to provide a faster, more effective treatment for Barrett’s esophagus and the only effective, non-surgical treatment for pancreatic cysts.

Aptiviti is a next generation, B2B research and due diligence platform serving Fortune 500 technology enterprises seeking more precise insight into the needs of CTOs, CIOs and other leaders driving their respective markets. Using non-traditional data science and automation, Aptiviti's market research and data visualization platform compresses the due diligence while increasing accuracy in market trends.

Sterifarma specializes in providing advanced solutions for hospitals that enhance patient safety and operational efficiency. Sterifarma serves as one of the leading suppliers of customized medical materials for surgical and post-surgical procedures.

Gentest is the first genetic testing marketplace, bringing together the widest variety of tests from the best laboratories in Brazil and the world on a single platform. Working with the top laboratories around the world Gentest aims to popularize genetics by simplifying the selection, purchase, shipment, processing, and interpretation of results with the support of an specialized and dedicated team.

Asthenis is a Patient Support Program company in Brazil focused on improving patient outcomes through personalized care. It provides tailored services such as medication management, education, and ongoing support, ensuring better adherence and quality of life for patients. Asthenis works closely with healthcare providers to bridge the gap between treatment and patient needs.

The Brilli Light Bulb Company offers a high-quality and energy efficient home lighting solution for consumers. Brilli is based on Tesla Technology™, a patented technology which produces a unique color spectrum that LED and other bulbs cannot. Brilli is on shelf at over 1,400 retail doors in the United States and is available online at Amazon, Wayfair, Staples etc...

CannaBlendz is a pioneering supplement that enhances the effects of cannabis through a patent-pending blend of natural ingredients. Designed to engage more body receptors, it promotes a healthier, more focused, and physically balanced cannabis experience, reducing brain fog and body stress. It comes in four targeted formulas: Recovery, MasterMind, Performance, and Good Times【6†source】【7†source】【9†source】.

Spexis AG is a leading specialty biopharmaceutical company with a strategic focus on chronic respiratory diseases, oncology and antimicrobial resistance. Spexis’ macrocyclic peptide technology platform has evolved into a renewable discovery engine for a wide range of therapeutic targets that have been leveraged by third party biotech firms. In December 2021, two companies – Polyphor and EnBiotix – teamed up to join forces and formed Spexis which is now publicly traded under the ticker symbol (Ticker.SW) on the SIX Swiss Exchange.